Baxter Young Investigator Awards

Novel technologies that reduce or eliminate risks associated with intravenous infusion therapy.  Therapeutic devices that support failing organs in critical care settings, specifically the intensive care unit. Diseases of interest include, but not limited to, acute kidney injury, liver failure, lung dysfunction, acute heart failure and sepsis.  Parenteral (novel drug compounds) and enteral (specialty formulas and devices) nutrition, NICU (novel pharmaceuticals, devices, human milk analyzers, feeding diagnostics, any device or drug or supplement which can help improve the nutritional status of a neonate or enhance its ability to grow and thrive), Monitoring and Diagnostics (enteral intolerance detection, calorie and protein intake, body composition).

Novel packaging and delivery technologies, differentiated generic pharmaceutical formulations, novel analytical test methods for pharmaceuticals, improved pharmaceutical compounding processes and methods, drug formulations that use safe complexation technologies to stabilize drugs in solution.

Broadly, technology solutions that address the needs of patients with chronic kidney disease (CKD), pre-dialysis and on-dialysis. These solutions include, but not limited to, predictive digital tools, home-based diagnostics, noninvasive remote monitoring and wearable devices. Novel approaches that drastically increase the quality of life and reduce the burden on dialysis patients (home or in-center). 

Novel tissue sealants, hemostatic agents, biomaterials, and other technologies/devices to improve surgical outcomes by addressing problematic bleeding, promoting wound healing and tissue repair, and/or preventing post-surgical complications.

Novel technology that improves outcomes for patients through intelligent diagnostics and connected care.  Product categories of interest (see examples from the Hillrom and Welch Allyn brands) include physical exam and diagnostics, diagnostic cardiology, vision screening and eye diagnostics, patient monitoring, non-invasive ventilation, and airway clearance. Technologies of interest may enable earlier diagnosis, accelerate patient recovery, or shift care closer to home.

Use of automation to reduce nurse fatigue, Ways to reduce data overload for clinicians (the right data at the right time),  Early detection of deterioration in patients who are incorrectly believed to be healthy, Novel wearable and non-contact devices for patient monitoring in the medical surgical floor and ICU, Best practices for collecting data from connected devices within hospital for the purpose of industry algorithm development, Optimizing nurse workflow with connected care in the ICU and medical surgical floor, Ways to improve nurse safety with connected care, Novel algorithm approach for recognizing health related trends in historic patient data from EMR (other sources) using Natural Language Processing or other, Improve patient charting workflow using natural Language Processing, Application of AI for predicting patient health during hospital journey (from entry to exit), Application of Machine vision for monitoring patient wellbeing, Applications of machine vision in the OR for improved patient safety, Benefits of vision systems in the OR, ICU, medical surgical floor, NICU, Novel non-intrusive methods of home health monitoring, Optimizing a “smart bed” platform to care for patients (e.g. embedded sensors), Practical applications of utilizing a bed platform for providing a therapy within the hospital, Early detection of a patient about to fall from hospital bed, Novel algorithm for reducing alarm fatigue, Novel applications to reduce pressure injuries in the hospital environment.